VANCOUVER, British Columbia, March 23, 2021 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to provide the following overview and update of its facility construction and Controlled Substance Dealer Licensing activities to-date.


Previous articleNuminus Deep Dive: Developing and Delivering Psychedelic-Assisted Psychotherapies
Next articlePsygen Industries Ltd. and Larose Ventures Ltd. Announce Reverse Takeover Transaction of 1290442 B.C. Ltd. by Psygen Industries Ltd. and Brokered Financing Led by Eight Capital and Canaccord